Suppr超能文献

血脂异常作为糖尿病神经病变发病机制中的一个促成因素。

Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy.

作者信息

Al-Ani Fakhir S, Al-Nimer Marwan S, Ali Fatima S

机构信息

Department of Physiology, College of Medicine, Al-Nahrin University, Baghdad, Iraq.

出版信息

Indian J Endocrinol Metab. 2011 Apr;15(2):110-4. doi: 10.4103/2230-8210.81940.

Abstract

OBJECTIVES

The pathogenesis of neuropathy in type 2 diabetes mellitus is multifactorial.Dyslipidemia may contribute to the development of diabetic neuropathy. This study aimed to assess the atherogenic lipid indices in type 2 diabetic patients with neuropathy.

MATERIAL AND METHODS

Fifty-one patients with type 2 diabetes mellitus and 31 healthy subjects were studied in the Unit of Neurophysiology at the University Hospital of Medical College, Al-Nahrin University in Baghdad, Iraq, from January 2002 to January 2003. Neuropathy total symptom score (NTSS), neuropathy impairment score in the lower leg (NIS-LL), and electrophysiological study of sensory (ulnar and sural) and motor (ulnar and common peroneal) nerves were used to assess nerve function. Fasting venous blood was obtained from each participant for determination of lipid profile and atherogenic lipid ratios.

RESULTS

The frequency of high blood pressure was significantly higher in neuropathic patients. The electrophysiology study revealed significant decrease in conduction velocity of ulnar (sensory and motor components), sural, and common peroneal nerves. The minimum F-wave latency of motor nerve was significantly prolonged. Among the lipid fractions, only high-density lipoprotein-cholesterol was significantly reduced by 14% of healthy participant's value. Atherogenic lipid ratios were significantly higher in diabetic patients than corresponding healthy ratios.

CONCLUSION

Metabolic lipid disturbances in terms of atherogenicity co-existwith neuropathy in type 2 diabetes mellitus, irrespective of duration of disease.

摘要

目的

2型糖尿病神经病变的发病机制是多因素的。血脂异常可能促使糖尿病神经病变的发展。本研究旨在评估2型糖尿病神经病变患者的致动脉粥样硬化脂质指标。

材料与方法

2002年1月至2003年1月,在伊拉克巴格达纳赫林大学医学院大学医院神经生理学科对51例2型糖尿病患者和31名健康受试者进行了研究。采用神经病变总症状评分(NTSS)、小腿神经病变损害评分(NIS-LL)以及感觉神经(尺神经和腓肠神经)和运动神经(尺神经和腓总神经)的电生理研究来评估神经功能。采集每位参与者的空腹静脉血以测定血脂谱和致动脉粥样硬化脂质比率。

结果

神经病变患者的高血压发生率显著更高。电生理研究显示尺神经(感觉和运动成分)、腓肠神经和腓总神经的传导速度显著降低。运动神经的最小F波潜伏期显著延长。在脂质组分中,只有高密度脂蛋白胆固醇显著降低,降至健康参与者值的14%。糖尿病患者的致动脉粥样硬化脂质比率显著高于相应的健康对照比率。

结论

无论病程长短,2型糖尿病患者在致动脉粥样硬化方面存在代谢性脂质紊乱,且与神经病变并存。

相似文献

1
Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy.
Indian J Endocrinol Metab. 2011 Apr;15(2):110-4. doi: 10.4103/2230-8210.81940.
2
Role of nitrosative and oxidative stress in neuropathy in patients with type 2 diabetes mellitus.
J Neurosci Rural Pract. 2012 Jan;3(1):41-4. doi: 10.4103/0976-3147.91932.
4
The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
Diabetes Res Clin Pract. 2005 Mar;67(3):211-9. doi: 10.1016/j.diabres.2004.07.017.
6
Serum levels of TGF-β1 in patients of diabetic peripheral neuropathy and its correlation with nerve conduction velocity in type 2 diabetes mellitus.
Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S135-9. doi: 10.1016/j.dsx.2015.10.011. Epub 2015 Oct 29.

引用本文的文献

1
Alternative therapeutic strategies in diabetes management.
World J Diabetes. 2024 Jun 15;15(6):1142-1161. doi: 10.4239/wjd.v15.i6.1142.
2
Effect of Ruzu Herbal Bitters on the Liver Function and Lipid Profile Parameters of Alloxan-Induced Diabetic Rats.
J Clin Exp Hepatol. 2024 May-Jun;14(3):100929. doi: 10.1016/j.jceh.2021.09.012. Epub 2021 Sep 23.
3
Assessment of Neuropathy by Temperature Threshold Testing in Type 2 Diabetes Mellitus.
Int J Appl Basic Med Res. 2024 Jan-Mar;14(1):54-59. doi: 10.4103/ijabmr.ijabmr_397_23. Epub 2024 Feb 20.
6
The metabolic and functional roles of sensory nerves in adipose tissues.
Nat Metab. 2023 Sep;5(9):1461-1474. doi: 10.1038/s42255-023-00868-x. Epub 2023 Sep 14.
8
An experimental study of rosuvastatin's analgesic effect and its interaction with etoricoxib, tramadol, amlodipine, and amitriptytline in albino mice.
Med J Armed Forces India. 2022 Sep;78(Suppl 1):S61-S68. doi: 10.1016/j.mjafi.2021.05.012. Epub 2021 Aug 27.

本文引用的文献

2
The approach to the management of the patient with neuropathic pain.
J Clin Endocrinol Metab. 2010 Nov;95(11):4802-11. doi: 10.1210/jc.2010-0892.
4
Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy.
South Med J. 2010 Mar;103(3):265-7. doi: 10.1097/SMJ.0b013e3181ce0e4d.
5
Hyperlipidemia: a new therapeutic target for diabetic neuropathy.
J Peripher Nerv Syst. 2009 Dec;14(4):257-67. doi: 10.1111/j.1529-8027.2009.00237.x.
7
Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.
Diabetes. 2009 Oct;58(10):2376-85. doi: 10.2337/db09-0047. Epub 2009 Jul 10.
8
Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy.
Int J Food Sci Nutr. 2009;60 Suppl 5:71-6. doi: 10.1080/09637480802406153. Epub 2009 Feb 11.
9
Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.
Atherosclerosis. 2009 Feb;202(2):582-8. doi: 10.1016/j.atherosclerosis.2008.04.042. Epub 2008 May 1.
10
Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.
Diabetes Res Clin Pract. 2008 Apr;80(1):e16-9. doi: 10.1016/j.diabres.2007.12.011. Epub 2008 Feb 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验